Arbitrator Voids Beckman’s Sale of HPV IP to Ventana;
Beckman Says Business Not Impacted
 
An arbitration panel has ruled that Beckman Coulter violated the terms of an original cross-license agreement between Institut Pasteur and Digene when it sold its human papillomavirus intellectual property to Ventana, Digene announced this week.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A research duo estimates in PLOS One the number of papers that have used misidentified cell lines.

UK's National Institute for Health and Care Excellence approves GlaxoSmithKline's SCID gene therapy despite cost.

Science reports that Brazilian researchers are petitioning for the reversal of budget cuts.

In PLOS this week: gene flow patterns in common ash, guidelines for using morpholinos in zebrafish, and more.